LARGE cap companies are now listed. There is an ERROR with the financial data with price showing $0.00. A new API is being sourced to rectify the issue.
FDA Calendar for biotech investing. Biotech stocks with key catalysts/binary events - FDA Approval/PDUFA, Advisory Committee and Phase 2 & 3 trial data releases dates.
PDUFA dates for biotech companies. Advisory Committee Meeting calendar dates also included. LARGE cap companies are now listed. There is an ERROR with the financial data with price showing $0.00. A new API is being sourced to rectify the issue. Note that most large cap companies do NOT announce PDUFA dates. Caution is advised as many are ESTIMATED dates. Biosimilars and sNDA/sBLA filings and resubmissions are only noted if a PDUFA date has been released by the company. No official PDUFA date = No entry. (e.g. Saxagliptin and dapagliflozin resubmission). Standard reviews use a 10 month estimate following filing acceptance for a NEW MOLECULAR ENTITY if no PDUFA date has been announced. Subscribe HERE to ensure you receive your weekly FREE copy of the BioPharmCatalyst Biotech Watchlist and/or our daily option of Biotech Price Movers and Pipeline Database updates.
Biotech and Healthcare IPO Calendar. Track the performance of past biotech IPOs and keep an eye out for upcoming listings.